TIMBER PHARMACEUTICALS, INC. TIMBER PHARMACEUTICALS LLC BIOPHARMX, INC. SECURED BRIDGE LOAN AGREEMENTSecured Bridge Loan Agreement • August 31st, 2023 • Timber Pharmaceuticals, Inc. • Pharmaceutical preparations • Delaware
Holder, LEO Pharma A/S, a Danish Aktieselskab, LEO Spiny Merger Sub, Inc., a Delaware corporation (“Merger Sub”), and Timber Parent have entered into an Agreement and Plan of Merger, dated as of August 20, 2023 (as amended, modified or supplemented from time to time, the “Merger Agreement”), pursuant to which Merger Sub will merge with and into Timber Parent (the “Merger”), with Timber Parent surviving the Merger as the surviving corporation and a wholly-owned subsidiary of Holder, subject to the terms and conditions described therein.
FORM OF AMENDMENT TO WARRANT OF TIMBER PHARMACEUTICALS, INC.Warrant Amendment • August 31st, 2023 • Timber Pharmaceuticals, Inc. • Pharmaceutical preparations
THIS AMENDMENT (this “Amendment”), dated as of August 25, 2023, to that certain Warrant, dated as of [●] (the “Warrant”), representing a right to purchase from Timber Pharmaceuticals, Inc., a Delaware corporation (the “Company”), [●] shares (the “Warrant Shares”) of the common stock of the Company, par value $0.001 (the “Shares”), is entered by and between the Company and the undersigned (the “Holder”). Capitalized terms used herein and not otherwise defined herein shall have the respective meanings set forth in the Warrant.
